Cerevel Therapeutics Holdings, Inc. EBITDA 2021-2024 | CERE
Cerevel Therapeutics Holdings, Inc. ebitda from 2021 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Cerevel Therapeutics Holdings, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-461 |
| 2022 | $-369 |
| 2021 | $-217 |
| 2020 | $-149 |
| 2019 | $-83 |
| 2018 | $-121 |
| Cerevel Therapeutics Holdings, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-147 |
| 2023-12-31 | $-144 |
| 2023-09-30 | $-114 |
| 2023-06-30 | $-100 |
| 2023-03-31 | $-103 |
| 2022-12-31 | $-112 |
| 2022-09-30 | $-96 |
| 2022-06-30 | $-91 |
| 2022-03-31 | $-71 |
| 2021-12-31 | $-63 |
| 2021-09-30 | $-54 |
| 2021-06-30 | $-50 |
| 2021-03-31 | $-51 |
| 2020-12-31 | $-42 |
| 2020-09-30 | $-34 |
| 2020-06-30 | $-35 |
| 2020-03-31 | $-38 |
